Exelixis, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +3.3%
EBITDA: +17.6%
EBIT: +22.9%
EPS: +39.3%
Free cash flow: +18.7%
Operating cash flow: +9.7%

Forward estimates

Revenue: +16.4%
EBITDA: +62.2%
EPS: +14.7%

Three-year CAGR

Revenue: +12.9%
EBITDA: +53.4%
EBIT: +63.0%
Net income: +62.5%
EPS: +71.6%
Free cash flow: +55.6%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.